Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Opgen Inc (OPGN)
Opgen Inc (OPGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,422
  • Shares Outstanding, K 5,514
  • Annual Sales, $ 2,610 K
  • Annual Income, $ -37,280 K
  • 60-Month Beta -0.22
  • Price/Sales 1.35
  • Price/Cash Flow N/A
  • Price/Book 0.41
Trade OPGN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -8.75
  • Most Recent Earnings -1.25 on 05/15/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.71
  • Number of Estimates 1
  • High Estimate -0.71
  • Low Estimate -0.71
  • Prior Year -2.60
  • Growth Rate Est. (year over year) +72.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6000 +4.52%
on 06/08/23
0.8680 -27.75%
on 05/10/23
-0.1130 (-15.27%)
since 05/08/23
3-Month
0.5500 +14.02%
on 05/02/23
1.6000 -60.81%
on 03/20/23
-0.3631 (-36.67%)
since 03/08/23
52-Week
0.5500 +14.02%
on 05/02/23
13.6000 -95.39%
on 06/24/22
-10.3409 (-94.28%)
since 06/08/22

Most Recent Stories

More News
Zacks.com featured highlights include Disney, Casey's General Stores, OpGen, Accelerate Diagnostics and Nektar Therapeutics

Disney, Casey's General Stores, OpGen, Accelerate Diagnostics and Nektar Therapeutics are part of the Zacks Screen of the Week article.

DIS : 92.53 (+0.01%)
NKTR : 0.6025 (+0.08%)
CASY : 219.81 (+0.98%)
AXDX : 0.6806 (-2.77%)
OPGN : 0.6271 (+1.05%)
Forget Bargain Hunting, Buy 5 Stocks With Rising P/E

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Disney (DIS), Casey's General Stores (CASY), OpGen (OPGN), Accelerate Diagnostics (AXDX) and Nektar...

DIS : 92.53 (+0.01%)
NKTR : 0.6025 (+0.08%)
CASY : 219.81 (+0.98%)
AXDX : 0.6806 (-2.77%)
OPGN : 0.6271 (+1.05%)
OpGen (NASDAQ: OPGN) Reports Positive Data from Clinical Trial for Unyvero as Diagnostic for UTI

OpGen, Inc. (NASDAQ: OPGN) is engaged as a precision medicine company that is focused on developing molecular diagnostics and bioinformatics

OPGN : 0.6271 (+1.05%)
Alignment Healthcare (ALHC) Reports Q2 Loss, Tops Revenue Estimates

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 76.92% and 8.85%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ALHC : 6.96 (+4.50%)
OPGN : 0.6271 (+1.05%)
LHC Group (LHCG) Lags Q2 Earnings and Revenue Estimates

LHC (LHCG) delivered earnings and revenue surprises of -25.76% and 3.80%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

LHCG : 169.81 (+0.47%)
OPGN : 0.6271 (+1.05%)
OpGen to Provide Business Update and Financial Results for the Second Quarter 2022 on August 11th at 4:30 p.m. Eastern Time

ROCKVILLE, Md., July 28, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a...

OPGN : 0.6271 (+1.05%)
OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven

Collaborators aim to develop and evaluate computation tools, including predictive models for whole genome sequencing-based antibiotic susceptibility...

OPGN : 0.6271 (+1.05%)
OpGen Announces Preliminary Unaudited Revenue and Cash Position for Second Quarter 2022 and Provides Business Update

Preliminary Total Revenue for Q2 2022 was approximately $1.0 millionCash as of June 30, 2022 was approximately $16.6 millionFirst commercial customer...

OPGN : 0.6271 (+1.05%)
OpGen Announces Publication of Results of Unyvero Hospitalized Pneumonia (HPN) Panel for Detection of Bacterial Respiratory Tract Pathogens from Serial Specimens Collected from Hospitalized COVID-19 Patients

Results were published in the European Journal of Clinical Microbiology & Infectious Diseases Serial specimen analysis confirms correct detection of...

OPGN : 0.6271 (+1.05%)
OpGen Announces 1,000th Patient Sample Enrolled in Clinical Trial for Unyvero Urinary Tract Infection Panel

Prospective multicenter trial for the Unyvero UTI panel recruited its 1,000th prospective patient sampleFourth trial site added to optimize enrollment for...

OPGN : 0.6271 (+1.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland.

See More

Key Turning Points

3rd Resistance Point 0.7014
2nd Resistance Point 0.6757
1st Resistance Point 0.6514
Last Price 0.6271
1st Support Level 0.6014
2nd Support Level 0.5757
3rd Support Level 0.5514

See More

52-Week High 13.6000
Fibonacci 61.8% 8.6149
Fibonacci 50% 7.0750
Fibonacci 38.2% 5.5351
Last Price 0.6271
52-Week Low 0.5500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar